Alexander V Gopanenko

9PUBLICATIONS
12CO-AUTHORS
NanomaterialsMicrobiology not elsewhere classifiedMedical infection agents (incl. prions)Micro- and nanosystemsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 27, 2025
Genetically Encoded In Vivo Ligation-Driven Targeted Drug Delivery System for Oncotheranostics.

Anastasiia S Obozina, Alexander V Gopanenko, Svetlana D Zvereva

|Nov 11, 2025
5-Formylcytosine is not a prevalent RNA modification in mammalian cells.

Jasmin A Dehnen, Alexander V Gopanenko, Carola Scholz

|Apr 13, 2023
Mutation at the Site of Hydroxylation in the Ribosomal Protein uL15 (RPL27a) Causes Specific Changes in the Repertoire of mRNAs Translated in Mammalian Cells.

Elizaveta A Zolotenkova, Alexander V Gopanenko, Alexey E Tupikin

|Sep 09, 2022
Reorganization of the Landscape of Translated mRNAs in NSUN2-Deficient Cells and Specific Features of NSUN2 Target mRNAs.

Olga A Kossinova, Alexander V Gopanenko, Elena S Babaylova

|Jun 10, 2022
Changes in the Transcriptome Caused by Mutations in the Ribosomal Protein uS10 Associated with a Predisposition to Colorectal Cancer.

Yueming Tian, Elena S Babaylova, Alexander V Gopanenko

|Dec 24, 2021
Deficiency of the Ribosomal Protein uL5 Leads to Significant Rearrangements of the Transcriptional and Translational Landscapes in Mammalian Cells.

Elena S Babaylova, Alexander V Gopanenko, Alexey E Tupikin

Pageof 2